Assessment of Human Mycotoxin Exposure in Hungary by Urinary Biomarker Determination and the Uncertainties of the Exposure Calculation: A Case Study

Biomarkers of Fumonisin Exposure in Pigs Fed the Maximum Recommended Level in Europe

This study investigated biomarkers of fumonisin exposure in pigs fed diets contaminated with fumonisins at the European Union's maximum recommended level. Pigs were assigned to either a fumonisin (FB) diet or a fumonisin plus AlgoClay (FB + AC) diet for durations of 4, 9, and 14 days. At 14 days, the plasma Sa1P:So1P ratio increased in pigs fed the FB diet, while the Sa:So ratio remained unchanged. In the liver, FB1 was detected at four days of exposure, with the concentration tending to increase through day 14. The Sa:So and C22-24:C16 ratios of 18:1-, 18:2-, and m18:1-ceramides were elevated at 9 and 14 days, respectively. In the kidneys, FB1 was only detectable at 14 days, and the Sa:So and C22-24:C16 ratios of 18:1-ceramides were increased. In both the liver and kidneys, the increase in the C22-24:C16 ratio was attributed to a reduction of C16 ceramides. In the lungs, no FB1 was detected; however, the Sa:So and Sa1P:So1P ratios increased, and C16 ceramide concentrations decreased at 14 days. Feeding the pigs the FB + AC diet resulted in a reduction of the FB1 tissue-to-feed ratio in the liver and kidneys but did not affect the Sa:So or Sa1P:So1P ratios. Interestingly, the decreases in C16 ceramides observed in the FB diet group were no longer detectable in the FB + AC group. Overall, these findings highlight the complexity of the relationship between FB1 tissue concentrations and sphingolipid changes, suggesting that a comprehensive analysis of multiple biomarkers is required to fully understand fumonisin's effects.

Exposure assessment of the European adult population to deoxynivalenol - Results from the HBM4EU Aligned Studies

Mycotoxins are natural toxins produced by fungi that may cause adverse health effects thus constituting a public health concern. Deoxynivalenol (DON), a mycotoxin affecting the immune system and causing intestinal disorders, was selected as a priority under the European Human Biomonitoring Initiative (HBM4EU). Urinary total DON levels (tDON) of 1270 participants from six countries were used to characterize the internal exposure of the adult European population and identify the most relevant determinants of exposure. tDON concentrations' P50 and P95 were in the range of 0.41-10.16 µg/L (0.39-9.05 µg/g crt) and 3.25-46.58 µg/L (2.12-33.50 µg/g crt) respectively. Higher tDON levels were observed for (i) male participants from France and Germany, (ii) samples collected in spring and summer, (iii) participants with a lower educational level, (iv) participants living in rural areas, (v) individuals without a job in France and Luxembourg, while in Portugal higher exposure was observed in working individuals, (vi) individuals with higher consumption of cereals and bread. The proportion of individuals with exposure levels exceeding the HBM-GV of 23 µg/L was 12.3 %, ranging from 0.8 % to 20.7 % in the individual countries. This study on mycotoxins exposure has used post harmonized questionnaire data and validated analytical methodologies for analysis and covered countries representing the four geographical regions of Europe, having produced much needed knowledge on the exposure of the European adult population to deoxynivalenol.

The Deoxynivalenol Challenge

This perspective examines four of the primary challenges that the mycotoxin deoxynivalenol (DON) presents to farmers, producers, and consumers. DON is one of the big five agriculturally important mycotoxins, resulting from Fusarium infection on grains, such as maize, barley, and wheat. In many countries, such as Canada, DON is the mycotoxin of principal concern because it can lead to major economic losses and stresses on food and feed security. The challenges discussed here include (1) understanding the different toxin profiles of Fusarium graminearum chemotypes/genotypes and the fate of these toxins upon interaction with the host crop, (2) the need for rapid analytical tests to measure DON and any masked or modified toxins in food and feed products, (3) DON exposure assessments in human populations to ensure health and safety, and (4) how contaminated food and feed products can be managed throughout the supply chain system. Despite decades of research, we are continuously learning new knowledge about DON and how best to manage it; however, there is still much work to be done. DON poses a very complex challenge that is being further exacerbated by climate change, evolving fungal populations, and the increased need for global food security.